Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM by Nicholas C. K. Valerie, Kumar Sanjiv, Oliver Mortusewicz, Si Min Zhang, Seher Alam, Maria J. Pires, Hannah Stigsdotter, Azita Rasti, Marie-France Langelier, Daniel Rehling, Adam Throup, Oryn Purewal-Sidhu, Matthieu Desroses, Jacob Onireti, Prasad Wakchaure, Ingrid Almlöf, Johan Boström, Luka Bevc, Giorgia Benzi, Pål Stenmark, John M. Pascal, Thomas Helleday, Brent D. G. Page, Mikael Altun

Get full text

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity by Rachel M. Hurley, Jill M. Wagner, Arun Kanakkanthara, Annapoorna Venkatachalam, Aaron M. Deisinger, Cristina Correia, Paula A. Schneider, Kevin L. Peterson, Elaine P. Macon, Ethan P. Heinzen, Kumar Sanjiv, Xiaonan Hou, Marc A. Becker, Matthew J. Maurer, Melissa C. Larson, Elizabeth M. Swisher, Hu Li, Ann L. Oberg, S. John Weroha, Ulrika Warpman Berglund, Thomas Helleday, Scott H. Kaufmann, Andrea E. Wahner Hendrickson

Get full text

Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy by Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday, Nikolas Herold

Get full text